Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Vitamin D and Breast Cancer Prevention: What’s the Current Evidence From Randomized Clinical Trials?

The study entitled “Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-analysis of Randomized Clinical Trials” has been recently judged suitable for publication in PLOS ONE and will be available at from 5pm ET on July 22nd 2013.

The authors belong to a multidisciplinary, international team led by Dr. Maddalena Barba, researcher at the Regina Elena National Cancer Institute of Rome, Central Italy.

"In recent years, the scientific evidence linking vitamin D to breast cancer has grown notably. Several systematic reviews including randomized clinical trials have recently focused on vitamin D and health outcomes. However, so far, no systematic review has specifically addressed the role of vitamin D supplementation in breast cancer prevention” says Prof. Antonio Giordano, an internationally renowned oncologist engaged for years in the fight against breast cancer.

"The conduct of a systematic review allows to collate all evidence that fits pre-specified eligibility criteria on a specific research question. It is always desirable to review a body of data systematically in that such an assessment holds the potentials to orient future steps and health priorities in a specific research setting. This approach is particularly appropriate when dealing with issues with broad reflections in terms of public health, such as breast cancer related outcomes” adds Prof. Giordano

In this study, the researchers focused on breast cancer, the most commonly diagnosed cancer and the second leading cause of cancer death in women from Western countries. "This systematic review was carried out in full agreement with the methods applied by the Cochrane collaboration, an international not-for-profit organization preparing, maintaining and promoting the accessibility of systematic reviews of the effects of health care and prevention worldwide. Our work contributes a comprehensive appraisal of the evidence stemming from randomized controlled trials on vitamin D supplementation for breast cancer prevention. Based on our results and considering the intrinsic limitations of the scientific evidence examined, vitamin D supplementation seems not to be associated with a reduced risk of breast cancer development in women. However, the scientific panorama related to the association of interest is still limited and overall inadequate to draw firm conclusions” clarifies Dr Barba.

“New trials specifically tailored on the vitamin D-cancer- binomious are in progress and should provide additional information in a few years’ time. Methodological tools and key tenets of vitamin D metabolism and biological activities will help interpret the upcoming results” concludes Prof. Giordano.

Barbara Colombo | Newswise
Further information:

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>